ARCHIVES

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

RFAs In Bladder, Prostate, Ok’d By DCBDC Advisors

March 1, 1991

Late Effects In Breast Cancer Treatment Found In Study

January 25, 2002

Some Of Community Contractors Won’t Survive, Some “Superb,” Some May Get More Time, Money

June 11, 1976

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

FDA’s Jane Henney

February 11, 1994